Education

Dr. Madrigrano shines a light on how hospitals have determined what are non-essential surgeries in these times of the COVID virus, how women are dealing with delayed surgeries related to their breast cancer, alternative therapies that are buying some time for women while they wait for restrictions to lift, and the opportunity for research comparing results from current innovations with more traditional approaches.

If you or someone you love has breast cancer, you might be concerned about how cancer treatments are continuing during the Coronavirus pandemic. Dr. Charles Cox, MD, joins Bloom via Skype to discuss how they’re adapting and precautions being taken.

Breast cancer screenings are being postponed during this COVID-19 crisis. So what does this mean for women who have concerns or are in the middle of treatment? Dr. Andrea Madrigrano from Rush University Medicine answers some of these questions.

Rush University’s Dr. Andrea Madgrigano speaks on the Empowered Patient Podcast about reducing her re-excision rate from 12% to 5% while utilizing the Kubtec MOZART 3D imaging specimen system.

During COVID-19 blood banks are reporting shortages. We encourage anyone who is willing & capable to give blood at your local donation center.

KUB Technologies, a U.S. medical device company that develops digital technologies used in the treatment of breast cancer, announced today it has been granted two new patents by the United States Patent and Trademark Office (USPTO).